Your browser doesn't support javascript.
loading
Breakthrough SARS-CoV-2 infections among recipients of tixagevimab-cilgavimab prophylaxis: A citywide real-world effectiveness study.
Lendacki, Frances R; Li, Linda; Forrest, Graeme N; Jordan, Leirah; Zelinski, Christy; Black, Stephanie R; Ison, Michael G; Seo, Jennifer Y.
Afiliación
  • Lendacki FR; Chicago Department of Public Health, Chicago, Illinois, USA.
  • Li L; Chicago Department of Public Health, Chicago, Illinois, USA.
  • Forrest GN; Rush University Medical Center, Chicago, Illinois, USA.
  • Jordan L; Chicago Department of Public Health, Chicago, Illinois, USA.
  • Zelinski C; Chicago Department of Public Health, Chicago, Illinois, USA.
  • Black SR; Chicago Department of Public Health, Chicago, Illinois, USA.
  • Ison MG; National Institutes of Health, Respiratory Diseases Branch, Division of Microbiology and Infectious Diseases, NIAID/NIH, Rockville, Maryland, USA.
  • Seo JY; Chicago Department of Public Health, Chicago, Illinois, USA.
Transpl Infect Dis ; 26(1): e14194, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37987112
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans / Middle aged Idioma: En Revista: Transpl Infect Dis Asunto de la revista: TRANSPLANTE Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans / Middle aged Idioma: En Revista: Transpl Infect Dis Asunto de la revista: TRANSPLANTE Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos